Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04246632 · ClinicalTrials.gov registry record · NA
CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)
A NA study of Colonoscopy, sponsored by Capso Vision.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 3
- Study locations
NCT04246632: Completed NA study of Colonoscopy, sponsored by Capso Vision.
NCT04246632 is a NA study of Colonoscopy that has completed, run by Capso Vision. The registered enrollment target is 112 participants, below the 496-participant average among 20 other Colonoscopy trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04246632, a NA study of Colonoscopy, has completed, sponsored by Capso Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 3
- Study locations
Study Summary
This non-significant risk pilot study is designed to evaluate safety and performance of the CapsoCam® Colon capsule endoscope in patients who meet the eligibility criteria and are scheduled for colonoscopy.
Primary Outcome
Determine the Accuracy of CapsoCam® to detect and measure size of colon polyps relative to the colonoscopy procedure.
Conditions Studied
Interventions
- DEVICE CapsoCam Colon Capsule Endoscopy
Study Locations (3)
California
- Silicon Valley Research Institute, Inc. - San Jose
- CapsoVision Research Clinic - Saratoga
Michigan
- West Michigan Clinical Research Center - Wyoming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2020-01-25 |
| Est. Completion | 2021-03-15 |
| Phase | NA |
What the finished NCT04246632 record still lists
NCT04246632 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 496-participant average among 20 other Colonoscopy trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 1 intervention - of which CapsoCam Colon Capsule Endoscopy is the first listed.
NCT04246632 reports a single indexed study location in California, Michigan.
Frequently Asked Questions
What is clinical trial NCT04246632 about?
NCT04246632 is a clinical study titled "CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)". This non-significant risk pilot study is designed to evaluate safety and performance of the CapsoCam® Colon capsule endoscope in patients who meet the eligibility criteria and are scheduled for colonoscopy.
What is the current status of trial NCT04246632?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2020-01-25. Estimated completion is 2021-03-15.
What conditions does trial NCT04246632 study?
This clinical trial studies the following conditions: Colonoscopy.
What interventions are being tested in trial NCT04246632?
The interventions under investigation include: CapsoCam Colon Capsule Endoscopy (DEVICE).
Who is sponsoring clinical trial NCT04246632?
This trial is sponsored by Capso Vision, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04246632 being conducted?
This trial has 3 study locations across California, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04246632's enrollment target sits among peer trials
112 17th of 20 higher than 4 of 20 other Colonoscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonoscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
-
Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy
COMPLETED · NA
-
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
COMPLETED · NA
-
Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study
COMPLETED · NA
-
EGD-assisted Bowel Preparation for Colonoscopy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI